Company Quick10K Filing
Balchem
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 33 $3,264
10-K 2020-02-21 Annual: 2019-12-31
10-Q 2019-11-05 Quarter: 2019-09-30
10-Q 2019-08-01 Quarter: 2019-06-30
10-Q 2019-05-03 Quarter: 2019-03-31
10-K 2019-02-28 Annual: 2018-12-31
10-Q 2018-11-06 Quarter: 2018-09-30
10-Q 2018-08-03 Quarter: 2018-06-30
10-Q 2018-05-04 Quarter: 2018-03-31
10-K 2018-03-01 Annual: 2017-12-31
10-Q 2017-11-07 Quarter: 2017-09-30
10-Q 2017-08-04 Quarter: 2017-06-30
10-Q 2017-05-09 Quarter: 2017-03-31
10-K 2017-02-28 Annual: 2016-12-31
10-Q 2016-11-04 Quarter: 2016-09-30
10-Q 2016-08-05 Quarter: 2016-06-30
10-Q 2016-05-10 Quarter: 2016-03-31
10-K 2016-02-29 Annual: 2015-12-31
10-Q 2015-11-04 Quarter: 2015-09-30
10-Q 2015-08-05 Quarter: 2015-06-30
10-Q 2015-05-07 Quarter: 2015-03-31
10-K 2015-02-27 Annual: 2014-12-31
10-Q 2014-11-10 Quarter: 2014-09-30
10-Q 2014-08-08 Quarter: 2014-06-30
10-Q 2014-05-05 Quarter: 2014-03-31
10-K 2014-02-27 Annual: 2013-12-31
10-Q 2013-11-05 Quarter: 2013-09-30
10-Q 2013-08-02 Quarter: 2013-06-30
10-Q 2013-05-03 Quarter: 2013-03-31
10-K 2013-02-25 Annual: 2012-12-31
10-Q 2012-11-02 Quarter: 2012-09-30
10-Q 2012-08-03 Quarter: 2012-06-30
10-Q 2012-05-10 Quarter: 2012-03-31
10-K 2012-02-29 Annual: 2011-12-31
10-Q 2011-11-08 Quarter: 2011-09-30
10-Q 2011-08-09 Quarter: 2011-06-30
10-Q 2011-05-06 Quarter: 2011-03-31
10-K 2011-02-28 Annual: 2010-12-31
10-Q 2010-11-05 Quarter: 2010-09-30
10-Q 2010-08-06 Quarter: 2010-06-30
10-Q 2010-05-10 Quarter: 2010-03-31
10-K 2010-03-12 Annual: 2009-12-31
8-K 2020-02-21 Earnings, Exhibits
8-K 2019-12-17 Amend Bylaw, Regulation FD, Exhibits
8-K 2019-12-13 Enter Agreement, Regulation FD, Exhibits
8-K 2019-11-05 Earnings, Exhibits
8-K 2019-09-12 Officers, Amend Bylaw, Exhibits
8-K 2019-08-02 Officers
8-K 2019-08-01 Earnings, Exhibits
8-K 2019-06-20 Shareholder Vote
8-K 2019-05-27 M&A, Regulation FD, Exhibits
8-K 2019-05-03 Earnings, Exhibits
8-K 2019-05-02 Enter Agreement, Regulation FD, Exhibits
8-K 2019-02-28 Earnings, Exhibits
8-K 2019-02-04 Officers, Exhibits
8-K 2018-12-13 Regulation FD, Exhibits
8-K 2018-11-06 Earnings, Exhibits
8-K 2018-09-26 Officers, Exhibits
8-K 2018-08-03 Earnings, Exhibits
8-K 2018-06-27 Enter Agreement, Leave Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2018-06-20 Shareholder Vote
8-K 2018-05-04 Earnings, Exhibits
8-K 2018-02-27 Earnings, Exhibits

Balchem Financials

BCPC Metrics, Comps, Filings

Annual | Quarterly

Business

Item 1.Business (All amounts in thousands, except share and per share data)

Balchem Corporation ("Balchem," the "Company," "we" or "us"), incorporated in the State of Maryland in 1967, is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. Our reportable segments are strategic businesses that offer products and services to different markets. We presently have four reportable segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products.

We sell our products through our own sales force, independent distributors and sales agents. Financial information concerning our business, business segments and geographic information appears in Management's Discussion and Analysis of Financial Condition and Results of Operations under Item 7 below and in the Notes to our Consolidated Financial Statements included under Item 8 below, which information is incorporated herein by reference.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
NewMarket (NEU) 4,509 28% 11.9 15% 1,767 1,178 2,202 606 258 429 5,114
Huntsman (HUN) 4,457 20% 14.9 -1% 8,896 6,220 8,908 1,761 -74 470 6,986
Chemours (CC) 4,249 25% 6.6 8% 7,433 6,604 5,876 1,496 607 1,184 7,868
Ingevity (NGVT) 4,073 37% 19.1 8% 2,130 1,729 1,219 448 173 283 5,412
Valvoline (VVV) 3,610 34% 17.0 11% 2,000 2,252 2,355 796 226 284 4,814
Olin (OLN) 3,566 15% 5.7 3% 9,235 6,464 6,654 1,010 270 1,212 6,855
Balchem (BCPC) 3,264 32% 21.4 7% 1,098 366 637 202 78 150 3,223
Sensient Technologies (SXT) 3,037 0% 14.8 8% 1,825 928 1,359 0 147 247 3,664
Rogers (ROG) 2,945 35% 16.8 7% 1,307 410 932 329 97 177 2,968
Platform Specialty Products (PAH) 2,714 43% -10.7 -9% 4,440 2,209 1,883 803 -395 -377 4,040
Cabot (CBT) 2,692 22% 7.4 8% 3,119 2,027 3,360 727 248 488 3,622
Quaker Chemical (KWR) 2,664 36% 29.2 8% 725 267 851 307 57 88 2,569
Polyone (POL) 2,374 21% 13.6 5% 2,931 2,360 3,521 752 142 270 3,689
WD-40 (WDFC) 2,238 73% 25.7 22% 313 160 317 231 69 88 2,264
Innospec (IOSP) 2,177 30% 11.7 6% 1,490 626 1,534 457 92 190 2,229
PQ Group (PQG) 2,089 24% 10.0 2% 4,442 2,722 1,598 392 77 413 4,151
Minerals Technologies (MTX) 2,077 25% 8.1 5% 3,149 1,728 1,813 454 154 338 2,739
Trinseo (TSE) 1,838 9% 7.6 5% 2,804 2,059 4,230 374 138 325 2,472
Kronos (KRO) 1,757 26% 7.5 6% 1,959 1,091 1,681 434 116 250 1,881
Tronox (TROX) 1,713 20% 11.5 -1% 5,416 4,487 2,066 422 -65 396 4,540

Balance Sheet ($MM)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash1151452095085394054
Accounts Receivable34423972608391100
Inventory1921255046576167
PP&E445355132159166190194
Assets272313377861881949964981
Accounts Payable1214122415332834
Long-Term Debt10298262261219156
Liabilities404046469418428347290
Stockholders' Equity232273331392464521617692
Income Statement ($MM)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue292310337541552553595644
Cost of Revenue206221240397384372406439
Gross Profit869097144168181189204
R&D334567912
SG&A27262833838285
Tax182021252031-220
Net Income3940455360569079
Cash Flow ($MM)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating45545685104108111119
Cash Investing-7-14-8-504-42-134-43-32
Cash Financing-1-1016262-26-19-69-71